Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06238232 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism: The GAPA Randomized Clinical Trial

Study acronym: GAPA
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified Show 11 more changesShow less
    • Sponsor changed: Qifu Li to Chongqing Medical University
    • Trial completed
    • Primary completion date changed from estimate of Dec 31, 2026 to May 1, 2026
    • Interventions: 68Ga-Pentixafor PET/CT (Diagnostic Test) to 68Ga-Pentixafor PET/CT (Diagnostic Test)
    • Eligibility criteria expanded, about 219 words
    • Secondary endpoints: 7 to 2
    • Site details revised
    • Collaborators revised (9)
    • Publications: 13 to 14
    • Study description expanded, about 3 words
    • Study title expanded, about 3 words
  2. Secondary endpoints: details revised at 6 of 7 entries
    • Collaborators: 8 to 9
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To compare the 68Ga-Pentixafor PET/CT and adrenal vein sampling on the long-term outcomes of primary aldosteronism (PA) patients with adrenal nodule (≥1cm)
Trial Details
NCT Number NCT06238232
Lead Sponsor Chongqing Medical University
Collaborators: The Affiliated Hospital Of Southwest Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Affiliated Hospital of Zhengzhou University, Second Affiliated Hospital, Zhejiang University, School of Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Changzhi Medical College, The People's Hospital of Chuxiong Yi Autonomous Prefecture, Tongji Hospital, Tongji Medical College, HUST
Conditions
(from sponsor)		 Primary Aldosteronism
Related terms Hyperaldosteronism
Enrollment 320 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov